137 related articles for article (PubMed ID: 22561792)
1. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
Miyata M; Hata T; Yamakawa H; Kagawa T; Yoshinari K; Yamazoe Y
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):41-7. PubMed ID: 22561792
[TBL] [Abstract][Full Text] [Related]
2. SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells.
Miyata M; Hata T; Yamazoe Y; Yoshinari K
Biochem Biophys Res Commun; 2014 Jan; 443(2):477-82. PubMed ID: 24321096
[TBL] [Abstract][Full Text] [Related]
3. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR.
Wistuba W; Gnewuch C; Liebisch G; Schmitz G; Langmann T
World J Gastroenterol; 2007 Aug; 13(31):4230-5. PubMed ID: 17696253
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
[TBL] [Abstract][Full Text] [Related]
5. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.
Hoeke MO; Heegsma J; Hoekstra M; Moshage H; Faber KN
PLoS One; 2014; 9(2):e88011. PubMed ID: 24498423
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice.
Jiang Y; Jin J; Iakova P; Hernandez JC; Jawanmardi N; Sullivan E; Guo GL; Timchenko NA; Darlington GJ
Mech Ageing Dev; 2013 Sep; 134(9):407-15. PubMed ID: 24007921
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
10. Pregnane X receptor is a target of farnesoid X receptor.
Jung D; Mangelsdorf DJ; Meyer UA
J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
[TBL] [Abstract][Full Text] [Related]
11. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.
Jung D; Podvinec M; Meyer UA; Mangelsdorf DJ; Fried M; Meier PJ; Kullak-Ublick GA
Gastroenterology; 2002 Jun; 122(7):1954-66. PubMed ID: 12055601
[TBL] [Abstract][Full Text] [Related]
12. LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.
Okuwaki M; Takada T; Iwayanagi Y; Koh S; Kariya Y; Fujii H; Suzuki H
Pharm Res; 2007 Feb; 24(2):390-8. PubMed ID: 17177110
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
14. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
Lu D; Wang S; Xie Q; Guo L; Wu B
Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells.
He F; Li J; Mu Y; Kuruba R; Ma Z; Wilson A; Alber S; Jiang Y; Stevens T; Watkins S; Pitt B; Xie W; Li S
Circ Res; 2006 Feb; 98(2):192-9. PubMed ID: 16357303
[TBL] [Abstract][Full Text] [Related]
18. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
Song KH; Li T; Owsley E; Strom S; Chiang JY
Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human liver delta-aminolevulinic acid synthase by bile acids.
Peyer AK; Jung D; Beer M; Gnerre C; Keogh A; Stroka D; Zavolan M; Meyer UA
Hepatology; 2007 Dec; 46(6):1960-70. PubMed ID: 17975826
[TBL] [Abstract][Full Text] [Related]
20. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
